Philip Cunningham

5.7k total citations
113 papers, 3.5k citations indexed

About

Philip Cunningham is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Philip Cunningham has authored 113 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Infectious Diseases, 47 papers in Epidemiology and 39 papers in Virology. Recurrent topics in Philip Cunningham's work include HIV/AIDS Research and Interventions (43 papers), HIV Research and Treatment (39 papers) and HIV/AIDS drug development and treatment (28 papers). Philip Cunningham is often cited by papers focused on HIV/AIDS Research and Interventions (43 papers), HIV Research and Treatment (39 papers) and HIV/AIDS drug development and treatment (28 papers). Philip Cunningham collaborates with scholars based in Australia, United Kingdom and United States. Philip Cunningham's co-authors include John Kaldor, Jason Grebely, Richard J Naftalin, Bruce J. Brew, Matthew Law, Basil Donovan, David A. Cooper, Gilbert R. Kaufmann, Tanya Applegate and John Zaunders and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Philip Cunningham

109 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Cunningham Australia	35	1.6k	1.5k	1.2k	787	360	113	3.5k
Hiroyuki Gatanaga Japan	36	2.8k 1.7×	1.5k 1.0×	2.1k 1.7×	499 0.6×	764 2.1×	252	4.8k
Stanley Read Canada	37	1.5k 0.9×	1.1k 0.8×	749 0.6×	150 0.2×	453 1.3×	142	3.4k
Gerrit Jan Weverling Netherlands	40	2.5k 1.6×	1.6k 1.0×	1.6k 1.3×	426 0.5×	559 1.6×	88	5.0k
Homayoon Farzadegan United States	28	2.9k 1.8×	1.7k 1.1×	2.5k 2.0×	446 0.6×	701 1.9×	77	4.9k
Paul R. Skolnik United States	35	1.9k 1.2×	1.5k 1.0×	1.8k 1.5×	230 0.3×	997 2.8×	77	4.2k
Wen‐Chun Liu Taiwan	28	3.0k 1.9×	1.6k 1.1×	395 0.3×	652 0.8×	1.0k 2.9×	148	5.1k
Sergio Lo Caputo Italy	30	1.7k 1.1×	860 0.6×	1.7k 1.4×	230 0.3×	896 2.5×	147	3.2k
Colin W. Shepard United States	25	1.2k 0.8×	3.4k 2.3×	303 0.2×	2.6k 3.3×	246 0.7×	58	4.5k
Patricia Reichelderfer United States	27	2.1k 1.3×	972 0.6×	1.9k 1.6×	106 0.1×	398 1.1×	56	3.4k
Eugenia Quirós-Roldán Italy	32	2.0k 1.3×	1.1k 0.7×	1.1k 0.9×	589 0.7×	712 2.0×	228	4.2k

Countries citing papers authored by Philip Cunningham

Since Specialization

Citations

This map shows the geographic impact of Philip Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Cunningham more than expected).

Fields of papers citing papers by Philip Cunningham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Cunningham. The network helps show where Philip Cunningham may publish in the future.

Co-authorship network of co-authors of Philip Cunningham

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Cunningham. A scholar is included among the top collaborators of Philip Cunningham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Cunningham. Philip Cunningham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hengel, Belinda, Rebecca Guy, Lorraine Anderson, et al.. (2025). Decentralised COVID‐19 molecular point‐of‐care testing: lessons from implementing a primary care‐based network in remote Australian communities. The Medical Journal of Australia. 222(4). 172–178. 1 indexed citations

King, Jonathan, Francesca Di Giallonardo, Ansari Shaik, et al.. (2024). Low HIV drug resistance prevalence among recently diagnosed HIV‐positive men who have sex with men in a setting of high PrEP use. Journal of the International AIDS Society. 27(7). e26308–e26308.

Maher, Lisa, Handan Wand, Robert Kemp, et al.. (2024). Utilising integrated bio-behavioural surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey. International Journal of Drug Policy. 144(Pt 1). 104576–104576.

Conway, Anna, Cherie Power, Anna McNulty, et al.. (2023). Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study. Open Forum Infectious Diseases. 10(11). ofad517–ofad517. 5 indexed citations

Lambert, Stephen B., Beth Catlett, Robert S. Ware, et al.. (2022). A national survey integrating clinical, laboratory, and WASH data to determine the typology of trachoma in Nauru. PLoS neglected tropical diseases. 16(4). e0010275–e0010275. 3 indexed citations

Bockel, David van, C. Mee Ling Munier, Stuart Turville, et al.. (2020). Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing. Viruses. 12(11). 1208–1208. 29 indexed citations

Catlett, Beth, F. Lamoury, Sahar Bajis, et al.. (2019). Evaluation of a hepatitis C virus core antigen assay from venepuncture and dried blood spot collected samples: A cohort study. Journal of Viral Hepatitis. 26(12). 1423–1430. 13 indexed citations

Lamoury, F., Behzad Hajarizadeh, Camelia Quek, et al.. (2018). Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples. Journal of Molecular Diagnostics. 20(5). 621–627. 19 indexed citations

Badman, Steven G., Avi J. Hakim, Rebecca Guy, et al.. (2018). A diagnostic evaluation of a molecular assay used for testing and treating anorectal chlamydia and gonorrhoea infections at the point-of-care in Papua New Guinea. Clinical Microbiology and Infection. 25(5). 623–627. 15 indexed citations

10.

Mühlbacher, A., Harald Schennach, Josef van Helden, et al.. (2012). Performance evaluation of a new fourth-generation HIV combination antigen–antibody assay. Medical Microbiology and Immunology. 202(1). 77–86. 32 indexed citations

11.

Post, Jeffrey J., et al.. (2011). Positive Epstein–Barr virus and cytomegalovirus IgM assays in primary HIV infection. Journal of Medical Virology. 83(8). 1406–1409. 12 indexed citations

12.

Day, Carolyn, Bethany White, Gregory J. Dore, et al.. (2010). Hepatitis B virus among injecting drug users in Sydney, Australia: Prevalence, vaccination and knowledge of status. Drug and Alcohol Dependence. 108(1-2). 134–137. 17 indexed citations

13.

Templeton, David J., Fengyi Jin, John Imrie, et al.. (2008). Prevalence, incidence and risk factors for pharyngeal chlamydia in the community based Health in Men (HIM) cohort of homosexual men in Sydney, Australia. Sexually Transmitted Infections. 84(5). 361–363. 36 indexed citations

14.

Jin, Fengyi, Garrett Prestage, Iryna Zablotska, et al.. (2007). High rates of sexually transmitted infections in HIV positive homosexual men: data from two community based cohorts. Sexually Transmitted Infections. 83(5). 397–399. 69 indexed citations

15.

Zaunders, John, Philip Cunningham, Anthony D. Kelleher, et al.. (1999). Potent Antiretroviral Therapy of Primary Human Immunodeficiency Virus Type 1 (HIV‐1) Infection: Partial Normalization of T Lymphocyte Subsets and Limited Reduction of HIV‐1 DNA Despite Clearance of Plasma Viremia. The Journal of Infectious Diseases. 180(2). 320–329. 100 indexed citations

16.

Bloch, Mark, Andrew Carr, E Vasak, Philip Cunningham, & Don Smith. (1999). The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination. American Journal of Obstetrics and Gynecology. 181(3). 760–761. 11 indexed citations

17.

Goldstein, David, Paul J. Hertzog, Deborah L. Couldwell, et al.. (1998). Administration of Imiquimod, an Interferon Inducer, in Asymptomatic Human Immunodeficiency Virus‐Infected Persons to Determine Safety and Biologic Response Modification. The Journal of Infectious Diseases. 178(3). 858–861. 60 indexed citations

18.

Kaufmann, Gilbert R., Chris Duncombe, John Zaunders, Philip Cunningham, & D.N. Cooper. (1998). Primary HIV-1 Infection: A Review of Clinical Manifestations, Immunologic and Virologic Changes. AIDS Patient Care and STDs. 12(10). 759–767. 15 indexed citations

19.

Kaufmann, Gilbert R., Chris Duncombe, Philip Cunningham, et al.. (1998). Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals. AIDS. 12(13). 1625–1630. 43 indexed citations

20.

Brew, Bruce J., Louise Pemberton, Philip Cunningham, & Matthew Law. (1997). Levels of Human Immunodeficiency Virus Type 1 RNA in Cerebrospinal Fluid Correlate with AIDS Dementia Stage. The Journal of Infectious Diseases. 175(4). 963–966. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact